We are live on ! Find out more
SC

Saturna Capital Portfolio holdings

AUM $7.13B
1-Year Est. Return 35.47%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+35.47%
3 Year Est. Return
+92.6%
5 Year Est. Return
+130.56%
10 Year Est. Return
+515.97%
AUM
$3.12B
AUM Growth
-$22.9M
Cap. Flow
-$50.6M
Cap. Flow %
-1.62%
Top 10 Hldgs %
26.9%
Holding
158
New
1
Increased
20
Reduced
36
Closed
2

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$6.31M
2
ABBV icon
AbbVie
ABBV
+$2.86M
3
TRMB icon
Trimble
TRMB
+$701K
4
RIO icon
Rio Tinto
RIO
+$560K
5
DD icon
DuPont de Nemours
DD
+$494K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$30M
2
LLY icon
Eli Lilly
LLY
+$13.1M
3
NKE icon
Nike
NKE
+$7.7M
4
PG icon
Procter & Gamble
PG
+$4.52M
5
GIS icon
General Mills
GIS
+$4.38M

Sector Composition

Rank Sector Weight
1 Technology 29.55%
2 Industrials 21.17%
3 Healthcare 19.22%
4 Consumer Staples 12.58%
5 Materials 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OVV icon
151
Ovintiv
OVV
$17.5B
$177K 0.01%
2,720
-120
-4% -$7.53K
ORAN
152
DELISTED
Orange
ORAN
$167K 0.01%
10,000
CDE icon
153
Coeur Mining
CDE
$15.6B
$106K ﹤0.01%
14,000
ULBI icon
154
Ultralife
ULBI
$88.3M
$96K ﹤0.01%
10,000
ENIA
155
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$88K ﹤0.01%
10,000
MN
156
DELISTED
MANNING & NAPIER, INC.
MN
$31K ﹤0.01%
10,000
CVS icon
157
CVS Health
CVS
$137B
-10,200
Closed -$635K
SNCR
158
DELISTED
Synchronoss Technologies
SNCR
-1,667
Closed -$158K

Similar funds

Saturna Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Saturna Capital held 158 positions worth $3.12B, down 0.73% from $3.14B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Trading was light in Q2 2018: portfolio turnover was 1.9%. Saturna Capital opened 1 new position and exited 2, leaving the 158-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Industrials and Healthcare.

  • Saturna Capital's largest Q2 2018 buy was Enbridge: 5,980 shares worth $213K.
  • Saturna Capital added most to Johnson & Johnson in Q2 2018, an estimated $6.31M increase.
  • Saturna Capital's biggest Q2 2018 reduction was Novartis, cutting an estimated $30M.
  • Saturna Capital fully exited CVS Health in Q2 2018, selling an estimated $635K.
  • Saturna Capital's ten largest holdings make up 27% of its $3.12B portfolio in Q2 2018.
  • Saturna Capital opened 1 new position and closed 2 in Q2 2018.
  • Saturna Capital's portfolio value fell 0.73% quarter-over-quarter to $3.12B.

Based on Saturna Capital's 13F filing for Q2 2018, filed 2 Aug 2018.